Literature DB >> 19083608

Treatment of Charcot foot and ankle with a prefabricated removable walker brace and custom insole.

Shawn Verity1, Michael Sochocki, John M Embil, Elly Trepman.   

Abstract

BACKGROUND: Removable walker braces have been used successfully to treat acute and chronic foot and ankle conditions including diabetic foot ulcers. We hypothesized that a removable walker brace may be successfully used in the management of the Charcot foot and ankle.
METHODS: Twenty-five feet and ankles with Charcot arthropathy in 21 patients (bilateral in 4 patients) were treated with a prefabricated, pneumatic removable walker brace fitted with a custom orthotic insole. Follow-up data were collected from patient interview, examination, and radiography.
RESULTS: Brace fitting was accomplished usually with a single visit to the prosthetist or pedorthist/orthotist. At the most recent evaluation, 17 (68%) feet and ankles had consolidation (stage III) of the Charcot arthropathy (average duration of brace use, 29+/-19 weeks) and were subsequently treated with rocker sole shoes, insoles, and ankle foot orthoses; 8 (32%) feet and ankles had ongoing brace treatment. Three feet developed new deformity during brace treatment, but average radiographic parameters of hindfoot to forefoot alignment had minimal change between initial and final radiographs at an average of 36+/-24 weeks after initial radiographic evaluation.
CONCLUSIONS: The prefabricated, pneumatic removable walker brace fitted with a custom insole was successful in the management of the Charcot foot and ankle and had a high satisfaction rate and safety profile despite frequent, albeit usually minor, complications.

Entities:  

Mesh:

Year:  2007        PMID: 19083608     DOI: 10.1016/j.fas.2007.10.002

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  9 in total

Review 1.  [Full contact plaster cast for conservative treatment of Charcot foot].

Authors:  K Trieb; F Ramadani; S G Hofstaetter
Journal:  Orthopade       Date:  2015-01       Impact factor: 1.087

2.  A case of diabetic Charcot arthropathy of the foot and ankle.

Authors:  John M Embil; Elly Trepman
Journal:  Nat Rev Endocrinol       Date:  2009-10       Impact factor: 43.330

3.  Outcome after protected full weightbearing treatment in an orthopedic device in diabetic neuropathic arthropathy (Charcot arthropathy): a comparison of unilaterally and bilaterally affected patients.

Authors:  Niklas Renner; Stephan Hermann Wirth; Georg Osterhoff; Thomas Böni; Martin Berli
Journal:  BMC Musculoskelet Disord       Date:  2016-12-29       Impact factor: 2.362

Review 4.  Shoe-Insole Technology for Injury Prevention in Walking.

Authors:  Hanatsu Nagano; Rezaul K Begg
Journal:  Sensors (Basel)       Date:  2018-05-08       Impact factor: 3.576

5.  Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study.

Authors:  Danielle A Griffiths; Michelle R Kaminski
Journal:  J Foot Ankle Res       Date:  2021-06-15       Impact factor: 2.303

6.  Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?

Authors:  Rachel H Albright; Robert M Joseph; Dane K Wukich; David G Armstrong; Adam E Fleischer
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

7.  Conservative and surgical treatment of the chronic Charcot foot and ankle.

Authors:  Mehmet Fatih Güven; Atakan Karabiber; Gökhan Kaynak; Tahir Oğüt
Journal:  Diabet Foot Ankle       Date:  2013-08-02

8.  Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review.

Authors:  Tamara E Milne; Joseph R Rogers; Ewan M Kinnear; Helen V Martin; Peter A Lazzarini; Thomas R Quinton; Frances M Boyle
Journal:  J Foot Ankle Res       Date:  2013-07-30       Impact factor: 2.303

Review 9.  Management of Ankle Charcot Neuroarthropathy: A Systematic Review.

Authors:  Ahmed ElSayed Galhoum; Vineet Trivedi; Mohamed Askar; Sergio Tejero; Mario Herrera-Pérez; Yousef AlRashidi; Victor Valderrabano
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.